Rheumatology Xagena

Xagena Mappa
Medical Meeting

Search results for "Anifrolumab"

Anifrolumab is an investigational, fully human monoclonal antibody that binds to subunit 1 of the type I IFN receptor, inhibiting the activity of all type I IFNs, which play a central role in lupus, i ...

Anifrolumab, a human monoclonal antibody to the type I IFN receptor subunit 1, had robust efficacy in a phase 2 study in patients with active systemic lupus erythematosus ( SLE ). The first phase 3 ...